COVID-19 and immunity: quo vadis?

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19).
• The nature and duration of protective immunity following SARS-CoV-2 infection are not fully understood.
• Insights into COVID-19 pathophysiology and treatment development necessitate a clear understanding of the immune response.

Purpose of the Study:

• To summarize current knowledge on the immune response during COVID-19.
• To identify existing gaps in understanding regarding SARS-CoV-2 immunity.
• To discuss the potential for natural infections to contribute to herd immunity.

Main Methods:

• Literature review and synthesis of existing research on COVID-19 immunology.
• Analysis of data pertaining to immune responses post-SARS-CoV-2 infection.
• Discussion of epidemiological concepts related to herd immunity in the context of COVID-19.

Main Results:

• Key aspects of the adaptive and innate immune responses to SARS-CoV-2 are characterized.
• Variability in the durability and effectiveness of natural immunity is observed.
• The contribution of natural infection to herd immunity remains a subject of ongoing investigation.

Conclusions:

• Further research is needed to fully elucidate the long-term protective immunity conferred by SARS-CoV-2 infection.
• Understanding immune responses is critical for developing effective vaccines and therapeutics for COVID-19.
• The feasibility of achieving herd immunity solely through natural infection requires careful consideration of public health implications.